iSpecimen Inc. (ISPC)
NASDAQ: ISPC · IEX Real-Time Price · USD
0.319
+0.033 (11.58%)
At close: Jul 11, 2024, 4:00 PM
0.343
+0.024 (7.49%)
Pre-market: Jul 12, 2024, 7:42 AM EDT

iSpecimen Statistics

Total Valuation

iSpecimen has a market cap or net worth of $4.17 million. The enterprise value is $1.77 million.

Market Cap 4.17M
Enterprise Value 1.77M

Important Dates

The next estimated earnings date is Wednesday, July 31, 2024, before market open.

Earnings Date Jul 31, 2024
Ex-Dividend Date n/a

Share Statistics

iSpecimen has 13.08 million shares outstanding. The number of shares has increased by 1.69% in one year.

Shares Outstanding 13.08M
Shares Change (YoY) +1.69%
Shares Change (QoQ) +0.62%
Owned by Insiders (%) 21.36%
Owned by Institutions (%) 2.29%
Float 8.27M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.45
Forward PS 0.47
PB Ratio 0.61
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 0.19
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 0.02.

Current Ratio 0.93
Quick Ratio 0.87
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -682.35

Financial Efficiency

Return on equity (ROE) is -105.30% and return on invested capital (ROIC) is -166.82%.

Return on Equity (ROE) -105.30%
Return on Assets (ROA) -74.40%
Return on Capital (ROIC) -166.82%
Revenue Per Employee $174,868
Profits Per Employee -$218,298
Employee Count 53
Asset Turnover 0.60
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -77.38% in the last 52 weeks. The beta is 1.60, so iSpecimen's price volatility has been higher than the market average.

Beta (5Y) 1.60
52-Week Price Change -77.38%
50-Day Moving Average 0.32
200-Day Moving Average 0.43
Relative Strength Index (RSI) 49.32
Average Volume (20 Days) 3,716,417

Short Selling Information

The latest short interest is 315,346, so 2.41% of the outstanding shares have been sold short.

Short Interest 315,346
Short Previous Month 670,079
Short % of Shares Out 2.41%
Short % of Float 3.81%
Short Ratio (days to cover) 0.08

Income Statement

In the last 12 months, iSpecimen had revenue of $9.27 million and -$11.57 million in losses. Loss per share was -$1.28.

Revenue 9.27M
Gross Profit 4.59M
Operating Income -11.63M
Pretax Income -11.57M
Net Income -11.57M
EBITDA -9.41M
EBIT -11.55M
Loss Per Share -$1.28
Full Income Statement

Balance Sheet

The company has $2.56 million in cash and $156,703 in debt, giving a net cash position of $2.40 million or $0.18 per share.

Cash & Cash Equivalents 2.56M
Total Debt 156,703
Net Cash 2.40M
Net Cash Per Share $0.18
Equity (Book Value) 6.81M
Book Value Per Share 0.52
Working Capital -414,722
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$5.05 million and capital expenditures -$3.48 million, giving a free cash flow of -$8.54 million.

Operating Cash Flow -5.05M
Capital Expenditures -3.48M
Free Cash Flow -8.54M
FCF Per Share -$0.94
Full Cash Flow Statement

Margins

Gross margin is 49.58%, with operating and profit margins of -125.46% and -124.84%.

Gross Margin 49.58%
Operating Margin -125.46%
Pretax Margin -124.84%
Profit Margin -124.84%
EBITDA Margin -101.54%
EBIT Margin -124.65%
FCF Margin -92.10%

Dividends & Yields

iSpecimen does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.69%
Shareholder Yield -1.69%
Earnings Yield -277.39%
FCF Yield -204.65%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

iSpecimen has an Altman Z-Score of -8.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -8.87
Piotroski F-Score 2